The Department of Chemistry is pleased to congratulate our majors who have been recognized as part of the 2022 100 Senior Honorary. Emma Giarracco Clio Hancock Qiao Jiao Pushkar Shinde Zoe Walker Sean Woo Claire Yohann Every year, the Emory Alumni Board and the Student Alumni Board recognize the success of outstanding students and identify…Continue readingChemistry majors recognized as part of 100 Senior Honorary
Author: news_qskxux
New resources are now available to undergraduate using chemistry’s online resources to navigate Chemistry Unbound coursework. In addition to the advising grid, students can now access a companion Advising Guide. The Guide has been updated for Spring 2022 to include: Updated Advising Guide The updated guide contains helpful and important new policies and procedures. To highlight a…Continue readingNew Chemistry Unbound resources available for students
Dr. Tim (Tianquan) Lian has received the 2022 Senior Experimental Award from the Physical Chemistry Division of the American Chemical Society.Continue readingTianquan (Tim) Lian receives ACS Senior Experimental Award
Emory chemist Rong Ma received a $150,000 Michelson Prize for her proposal to harness the mechanical processes of cells as a new approach in the long-running quest to develop cancer vaccines.Continue readingNew approach in quest for cancer vaccines nets Emory chemist a Michelson Prize
RODRIGO SALINAS came to Emory to study chemistry, but since he arrived, he’s found that and so much more. In fact, he says Emory has helped him find his voice—both as a leader and an artist.Continue readingChemist Rodrigo Salinas (24C) featured in Emory Magazine
Undergraduate alum Kevin Welsher is part of the 2021 cohort of 40 Under 40. The prestigious recognition from the Emory Alumni Association potlights selected alumni across a variety of vocations for having made a significant impact in business, research, leadership, public service and/or philanthropic endeavors. Continue readingChemistry alum Kevin Welsher (EC ’05) is part of Emory’s 2021 40 Under Forty
Categories
Molnupiravir and Drug Development at Emory
Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory